Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.Intra-assay Precision (Precision within an assay)Intra-assay Precision (Precision within an assay):Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.Intra-Assay CV: ≤4.8%
Inter-assay Precision (Precision between assays):Three samples of known concentration were tested in five separate assays to assess inter-assay precision.
Inter-Assay CV: ≤7.9%
Sample Type | Average(%) | Recovery Range(%) |
Serum | 81 | 80-87 |
Plasma | 83 | 80-89 |
Sample Type
Average(%)
Recovery Range(%)
Serum
81
80-87
Plasma
83
80-89
Sample Type
Average(%)
Recovery Range(%)
Sample Type
Sample Type
Sample TypeSample TypeAverage(%)
Average(%)
Average(%)Average(%)Recovery Range(%)
Recovery Range(%)
Recovery Range(%)Recovery Range(%)Serum
81
80-87
Serum
Serum
SerumSerumSerum81
81
818180-87
80-87
80-8780-87Plasma
83
80-89
Plasma
Plasma
PlasmaPlasmaPlasma83
83
838380-89
80-89
80-8980-89Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 96-105% | 109-119% | 88-97% | 85-94% |
EDTA plasma(n=5) | 87-97% | 84-94% | 84-94% | 100-111% |
heparin plasma(n=5) | 109-119% | 85-96% | 105-114% | 97-107% |
Sample
1:2
1:4
1:8
1:16
serum(n=5)
96-105%
109-119%
88-97%
85-94%
EDTA plasma(n=5)
87-97%
84-94%
84-94%
100-111%
heparin plasma(n=5)
109-119%
85-96%
105-114%
97-107%
Sample
1:2
1:4
1:8
1:16
Sample
Sample
SampleSample1:2
1:2
1:21:21:4
1:4
1:41:41:8
1:8
1:81:81:16
1:16
1:161:16serum(n=5)
96-105%
109-119%
88-97%
85-94%
serum(n=5)
serum(n=5)
serum(n=5)serum(n=5)96-105%
96-105%
96-105%96-105%109-119%
109-119%
109-119%109-119%88-97%
88-97%
88-97%88-97%85-94%
85-94%
85-94%85-94%EDTA plasma(n=5)
87-97%
84-94%
84-94%
100-111%
EDTA plasma(n=5)
EDTA plasma(n=5)
EDTA plasma(n=5)EDTA plasma(n=5)87-97%
87-97%
87-97%87-97%84-94%
84-94%
84-94%84-94%84-94%
84-94%
84-94%84-94%100-111%
100-111%
100-111%100-111%heparin plasma(n=5)
109-119%
85-96%
105-114%
97-107%
heparin plasma(n=5)
heparin plasma(n=5)
heparin plasma(n=5)heparin plasma(n=5)109-119%
109-119%
109-119%109-119%85-96%
85-96%
85-96%85-96%105-114%
105-114%
105-114%105-114%97-107%
97-107%
97-107%97-107%

EIAab®
伊艾博(武汉)科技股份有限公司专注于生命科学领域的产品与技术研发,拥有基因重组、免疫层析、标记、抗体配对、包被等核心技术优势。主要自主研发产品:酶联免疫/化学发光试剂盒,多/单克隆抗体,重组蛋白(原核表达为主),807种原代细胞(iCell®品牌)及专用培养基等;技术服务:线上产品定制,基因克隆与表达/基因敲除,人/动物组织源的原代细胞分离、培养、复苏、STR检测分析等。公司业务还涉及生命科学相关信息化领域:蛋白aa序列及3D结构数据库(aa3D),样品检测资源库(SPDB),人工智能实验室(AI-Lab)等。


全球供应
EIAab具有自营进出口资格。 所有产品的制造和组装均严格按照EIAab制订的标准执行。 EIAab还在大力开展自主创新,逐步减少原料进口,降低生产成本,进一步降低大学和生命科学研究中心的科研经费。


EIAab® 技术
EIAab的办公地址和研发中心厂区位于中国武汉东湖高新技术开发区生物医药园区一期。 公司配备有超低温冷藏中心,血液采样和预处理中心以及实验动物养殖场。 EIAab员工至少拥有学士学位,大多数还拥有硕士学位和博士学位。 他们的专业涵盖了生命科学领域的各种相关专业,如医学免疫学,临床医学,药学,蛋白质组学,生物技术,农学,环境科学,生物信息学,IT编程语言等。


发展前景
21世纪,世界科学技术的重心已悄然转向生物技术和人工智能。生命科学已经成为了生物技术和生物医学工程技术的前沿和核心战场。 新技术层出不穷,应用前景广阔,生命科学几乎涉及到各个领域,这也促使了我们公司将成为一个活跃,开放和高技术的企业。